MarketCap
Facebook
X
TelegramQuarterly report 2023-Q1
added 05-15-2023
Sorrento Therapeutics ROA Ratio 2011-2026 | SRNE
Annual ROA Ratio Sorrento Therapeutics
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -61.65 | -55.7 | -52.38 | -32.61 | 2.12 | -15.17 | -13.34 | -24.49 | -23.67 | -71.45 | -70.84 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.12 | -71.45 | -38.11 |
Quarterly ROA Ratio Sorrento Therapeutics
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -94.17 | -54.04 | -74.83 | -76.19 | -62.87 | -57.71 | -50.27 | -50.03 | -43.14 | -55.7 | -53.62 | -49.49 | -45.16 | -52.38 | -49.09 | -45.12 | -46.77 | -32.61 | -13.41 | -6.31 | 2.24 | 2.12 | -13.56 | -9.12 | -16.62 | -15.17 | -18.47 | -22.7 | -15.1 | -14.24 | -12.51 | -17.61 | -20.39 | -24.49 | -22.1 | -20.35 | -38.05 | -50.96 | -122.41 | -190.23 | -238.01 | -156.26 | -171.63 | -115.55 | -67.91 | -54.16 | -15.37 | -23.81 | -14.98 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 2.24 | -238.01 | -51.23 |
ROA Ratio of other stocks in the Biotechnology industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
FSD Pharma
HUGE
|
-241.53 | - | 5743.5 % | $ 69.7 M |  Canada |
 |
MorphoSys AG
MOR
|
-20.13 | - | 2.43 % | $ 254 M |  Germany |
 |
AgeX Therapeutics
AGE
|
-275.96 | - | -10.17 % | $ 12.2 K |  USA |
 |
I-Mab
IMAB
|
7.43 | - | - | $ 866 M |  China |
 |
Midatech Pharma plc
MTP
|
-42.28 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
3.33 | - | - | $ 40.3 B | USA |
 |
Biophytis SA
BPTS
|
-89.6 | - | -13.47 % | $ 169 M |  France |
 |
Genfit SA
GNFT
|
23.87 | - | 2.54 % | $ 160 B | France |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-53.39 | - | -1.52 % | $ 24.7 M | USA |
 |
Enlivex Therapeutics Ltd.
ENLV
|
53.1 | $ 0.81 | -3.11 % | $ 37 M |  Israel |
 |
Exelixis
EXEL
|
27.51 | $ 46.21 | -5.11 % | $ 12.5 B | USA |
 |
Athira Pharma
ATHA
|
-114.6 | - | - | $ 269 M | USA |
 |
Fortress Biotech
FBIO
|
3.67 | $ 2.43 | -4.71 % | $ 67.8 M | USA |
 |
Heron Therapeutics
HRTX
|
-7.89 | $ 1.24 | -5.73 % | $ 207 M | USA |
 |
InflaRx N.V.
IFRX
|
-82.65 | $ 2.86 | 14.2 % | $ 192 M | Germany |
 |
Ionis Pharmaceuticals
IONS
|
-6.51 | $ 75.53 | -1.72 % | $ 12.1 B | USA |
 |
BioNTech SE
BNTX
|
65.02 | $ 92.4 | -3.0 % | $ 27.2 B | Germany |
 |
Институт стволовых клеток человека
ISKJ
|
4.82 | - | - | - |  Russia |
 |
Kymera Therapeutics
KYMR
|
-17.86 | $ 85.56 | -0.81 % | $ 7.23 B | USA |
 |
Checkmate Pharmaceuticals
CMPI
|
-77.89 | - | - | $ 231 M | USA |
 |
Ligand Pharmaceuticals Incorporated
LGND
|
-0.43 | $ 212.11 | -8.79 % | $ 3.88 B | USA |
 |
ACADIA Pharmaceuticals
ACAD
|
19.07 | $ 22.02 | 2.51 % | $ 3.65 B | USA |
 |
Mirum Pharmaceuticals
MIRM
|
-2.77 | $ 100.27 | -8.92 % | $ 5.03 B | USA |
 |
MannKind Corporation
MNKD
|
0.74 | $ 3.59 | 0.7 % | $ 1.1 B | USA |
 |
Advaxis
ADXS
|
-289.96 | - | -9.65 % | $ 45.9 M | USA |
 |
Esperion Therapeutics
ESPR
|
-4.87 | $ 3.15 | - | $ 655 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-103.3 | $ 3.65 | 8.96 % | $ 6.01 M | Israel |
 |
Aeterna Zentaris
AEZS
|
-10.45 | - | 5.93 % | $ 314 M | Canada |
 |
Genprex
GNPX
|
-159.75 | $ 0.88 | -1.48 % | $ 821 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-19.95 | - | - | $ 1.01 B | USA |
 |
Matinas BioPharma Holdings
MTNB
|
-143.52 | $ 0.65 | -4.03 % | $ 3.56 M | USA |
 |
CureVac N.V.
CVAC
|
-35.55 | - | - | $ 867 M | Germany |
 |
Applied Genetic Technologies Corporation
AGTC
|
-27.57 | - | - | $ 26.5 M | USA |
 |
AIkido Pharma
AIKI
|
-19.87 | - | 1.93 % | $ 17.4 M | USA |
 |
Nanobiotix S.A.
NBTX
|
-46.19 | $ 43.46 | 3.82 % | $ 286 B | France |
 |
Akero Therapeutics
AKRO
|
-30.52 | - | - | $ 3.67 B | USA |
 |
Aptose Biosciences
APTO
|
-254.37 | - | -45.71 % | $ 1.2 M | Canada |
 |
Aptinyx
APTX
|
-97.25 | - | -39.0 % | $ 4.57 M | USA |
 |
Akouos
AKUS
|
-31.09 | - | 0.23 % | $ 488 M | USA |
 |
Albireo Pharma
ALBO
|
-11.27 | - | -0.23 % | $ 916 M | USA |
 |
Allakos
ALLK
|
-76.23 | - | - | $ 28.6 M | USA |
 |
AlloVir
ALVR
|
-35.68 | - | 4.14 % | $ 49.1 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
-3.73 | $ 21.33 | -11.75 % | $ 2.71 B | USA |
 |
Allena Pharmaceuticals
ALNA
|
-140.01 | - | 3.16 % | $ 1.9 M | USA |
 |
Genmab A/S
GMAB
|
22.5 | $ 27.16 | -2.62 % | $ 16.8 B |  Danmark |
 |
Ampio Pharmaceuticals
AMPE
|
-150.49 | - | -11.43 % | $ 502 K | USA |
|
Applied Molecular Transport
AMTI
|
-117.57 | - | - | $ 10.1 M | USA |
 |
Alpine Immune Sciences
ALPN
|
-20.15 | - | - | $ 2.17 B | USA |
 |
Aileron Therapeutics
ALRN
|
-206.44 | - | 10.36 % | $ 9.8 M | USA |
 |
Applied Therapeutics
APLT
|
-218.41 | - | - | $ 8.42 M | USA |